APG777
APG777-105
Phase 1 small_molecule active
Quick answer
APG777 for Asthma is a Phase 1 program (small_molecule) at Apogee Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Apogee Therapeutics
- Indication
- Asthma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active